Publications by authors named "Alan Siroy"

Claim this Profile
A
Anti-MDA-5 Dermatomyositis With Development of Drug-Mediated Necrolytic Skin Lesions.
Robert A Case, Vishal Patel, Carolina Mejia-Otero, Alan E Siroy, Divya C Patel

J Investig Med High Impact Case Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and histopathologic features differentiating acute generalized exanthematous pustulosis and pustular psoriasis: A retrospective series.
James Isom, Diana S Braswell, Alan Siroy, Jena Auerbach, Kiran Motaparthi

J Am Acad Dermatol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel diagnostic imaging features of facial lupus panniculitis: ultrasound, CT, and MR imaging with histopathology correlate.
Heather Kimball, David Kimball, Alan Siroy, Ibrahim Sacit Tuna, Brian J Boyce

Clin Imaging· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactive Perforating Collagenosis in End-Stage Renal Disease: Not All that Itches Is Uremic Pruritis!
Harini Bejjanki, Alan E Siroy, Abhilash Koratala

Am J Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravascular nevus cell aggregate in axillary lymph node mimicking metastatic breast carcinoma.
Jaya Ruth Asirvatham, Alan Siroy, Jena Auerbach, David Hernandez-Gonzalo

Breast J· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy.
Shakuntala H Mauzo, Michael T Tetzlaff, Denái R Milton, Alan E Siroy, Priyadharsini Nagarajan

Cancers (Basel)· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma.
Meredith McKean, Junna Oba, Junsheng Ma, Katherine G Roth, Wei-Lien Wang, Alan E Siroy

J Invest Dermatol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granuloma Annulare Secondary to Vemurafenib Therapy for Lung Adenocarcinoma.
Helena A Jenkinson, Alan E Siroy, Adrienne Choksi

J Drugs Dermatol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological features and clinical outcomes associated with TP53 and BRAF mutations in cutaneous melanoma patients.
Dae Won Kim, Lauren E Haydu, Aron Y Joon, Roland L Bassett, Alan E Siroy

Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
Alan E Siroy, Phyu P Aung, Carlos A Torres-Cabala, Michael T Tetzlaff, Priyadharsini Nagarajan

Hum Pathol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
Jason Roszik, Lauren E Haydu, Kenneth R Hess, Junna Oba, Aron Y Joon, Alan E Siroy

BMC Med· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma.
Lynette M Sholl, Aleodor Andea, Julia A Bridge, Liang Cheng, Michael A Davies, Alan Siroy

Arch Pathol Lab Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.
Jason Roszik, Chang-Jiun Wu, Alan E Siroy, Alexander J Lazar, Michael A Davies

Sci Rep· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations.
David L Stockman, Jonathan L Curry, Carlos A Torres-Cabala, Ian R Watson, Alan E Siroy

J Cutan Pathol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.
Alan E Siroy, Genevieve M Boland, Denái R Milton, Jason Roszik, Silva Frankian

J Invest Dermatol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutations.
Amanda D Bucheit, Guo Chen, Alan Siroy, Michael Tetzlaff, Russell Broaddus

Clin Cancer Res· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC1 is expressed at high frequency in early-stage basal-like triple-negative breast cancer.
Alan Siroy, Fadi W Abdul-Karim, John Miedler, Nancy Fong, Pingfu Fu

Hum Pathol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach: chest wall cyst excised by MIS.
Yazan N AlJamal, Alan E Siroy, David R Farley

J Surg Case Rep· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Crohn disease: a rare cutaneous entity.
Alan Siroy, Jay Wasman

Arch Pathol Lab Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary melanoma of the bladder.
Alan E Siroy, Gregory T MacLennan

J Urol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy.
Christine A DeWitt, Alan E Siroy, Stephen P Stone

J Am Acad Dermatol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis